Literature DB >> 16263206

Complexation of daunomycin with a DNA oligomer in the presence of an aromatic vitamin (B2) determined by NMR spectroscopy.

M P Evstigneev1, Yu V Mykhina, D B Davies.   

Abstract

The effect of simultaneous binding of the anthracycline antibiotic Daunomycin (DAU) and the Vitamin B2 derivative, Flavin-mononucleotide (FMN), with the DNA oligomer, d(TGCA)2, in solution has been investigated quantitatively by 1I-NMR spectroscopy (500 MHz). The equilibrium reaction constants and the thermodynamical parameters (DeltaH, DeltaS) of the hetero-association FMN-DAU and complexation of FMN with d(TGCA)2 have been determined by analysis of the concentration and temperature dependences of chemical shifts of the aromatic protons in terms of a competitive binding model. A criterion for discrimination between hetero-association and DNA complexation has been developed and applied to the analysis of the simultaneous binding of the antibiotic and the vitamin with DNA. Under the conditions of the experiment, it is found that both the hetero-association of FMN with DAU and the complexation of FMN with DNA contribute approximately equally to the decrease of DAU binding with DNA oligomer. Such competitive complexation of aromatic vitamin and drug with DNA could affect the biological activity of such drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263206     DOI: 10.1016/j.bpc.2005.08.007

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  6 in total

1.  Attenuation of acridine mutagen ICR-191--DNA interactions and DNA damage by the mutagen interceptor chlorophyllin.

Authors:  Monika Pietrzak; H Dorota Halicka; Zbigniew Wieczorek; Jolanta Wieczorek; Zbigniew Darzynkiewicz
Journal:  Biophys Chem       Date:  2008-03-30       Impact factor: 2.352

2.  On the reliability of quantitation of biological effect in drug-interceptor-DNA systems.

Authors:  Anatoly S Buchelnikov; Vladyslav P Evstigneev; Leticia E Rodríguez Oropeza; Maxim P Evstigneev
Journal:  Eur Biophys J       Date:  2013-02-11       Impact factor: 1.733

3.  Quantification of the interceptor action of caffeine on the in vitro biological effect of the anti-tumour agent topotecan.

Authors:  M P Evstigneev; A A Mosunov; V P Evstigneev; H G Parkes; D B Davies
Journal:  Eur Biophys J       Date:  2011-06-15       Impact factor: 1.733

4.  General analysis of competitive binding in drug-interceptor-DNA systems.

Authors:  A S Buchelnikov; A A Hernandez Santiago; M Gonzalez Flores; R Vazquez Ramirez; D B Davies; M P Evstigneev
Journal:  Eur Biophys J       Date:  2012-01-03       Impact factor: 1.733

5.  Complexation of anthracycline drugs with DNA in the presence of caffeine.

Authors:  M P Evstigneev; V V Khomich; D B Davies
Journal:  Eur Biophys J       Date:  2006-10-24       Impact factor: 1.733

6.  Riboflavin-containing telodendrimer nanocarriers for efficient doxorubicin delivery: High loading capacity, increased stability, and improved anticancer efficacy.

Authors:  Dandan Guo; Changying Shi; Xu Wang; Lili Wang; Shengle Zhang; Juntao Luo
Journal:  Biomaterials       Date:  2017-06-30       Impact factor: 12.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.